At A Glance: This Prescriber in 2012
Self-Reported Primary Specialty
Rank: 180 out of 294
Rank: 205 out of 294
How Does This Prescriber Compare to Peers?
Dangerous Drugs to Seniors
Brand Name Drugs
17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.
$93 was the average price of a prescription from this provider, compared to $118 among peers.
Prescriptions per Patient
6 is the average number of prescriptions (including refills) per patient, compared to an average of 16.
This Prescriber's Drugs
Search for a Drug
5 questions to ask about a new drug »
via Consumer Health Choices
Compare different prescription drugs »
via Consumer Reports
Click to Filter by Category
This provider is among the top 10 prescribers of
this drug in the country.
This Drug's Rank
Total Prescriptions Filled
|Category||For this Prescriber||
For All Prescribers in
This Specialty in Maryland
Buspirone is used to treat ... +
Buspirone is used to treat anxiety disorders or in the short-term treatment of symptoms of anxiety. More info »
VENLAFAXINE HCL ER
Venlafaxine is used to trea... +
Venlafaxine is used to treat depression. Venlafaxine extended-release (long-acting) capsules are also used to treat generalized anxiety disorder (GAD; excessive worrying that is difficult to control), social anxiety disorder (extreme fear of interacting with others or performing in front of others that interferes with normal life), and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Venlafaxine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amounts of serotonin and norepinephrine, natural substances in the brain that help maintain mental balance. More info »
Trazodone is used to treat ... +
Sertraline is used to treat... +
About This Data
- No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
- This provider's address and specialty information was last updated on Dec. 7, 2009.